Hydromorph Contin - Controlled Release Capsule 24 mg (2019-04-12)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Hydromorph Contin - Controlled Release Capsule 24 mg
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 135272, 135529, 136263, 137226, 137482, 137934, 138568, 138820, 139454, 139842 | Hydromorph Contin - Controlled Release Capsule 24 mg | - Recalling Firm
- Purdue Pharma
- 575 Granite Court
- Pickering
- L1W 3W8
- Ontario
- CANADA
- Marketing Authorization Holder
- Purdue Pharma
- 575 Granite Court
- Pickering
- L1W 3W8
- Ontario
- CANADA
| Capsule | DIN 02125382 | Hydromorphone hydrochloride 24 mg |
Affected lots may contain hydromorphone levels outside of the labelled claim.
Wholesalers, Retailers, Healthcare Establishments